InnoCan Pharma's total assets for Q4 2023 were $9.04M, an increase of 30.26% from the previous quarter. INNPF total liabilities were $4.33M for the fiscal quarter, a 69.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.